THOMAS, Astrid Maria
 Distribuzione geografica
Continente #
EU - Europa 7.017
NA - Nord America 6.859
AS - Asia 3.155
Continente sconosciuto - Info sul continente non disponibili 21
SA - Sud America 18
OC - Oceania 10
AF - Africa 5
Totale 17.085
Nazione #
US - Stati Uniti d'America 6.837
IT - Italia 1.409
CN - Cina 1.408
UA - Ucraina 1.357
IE - Irlanda 1.135
TR - Turchia 853
GB - Regno Unito 848
SE - Svezia 677
FR - Francia 616
SG - Singapore 553
DE - Germania 393
IN - India 257
FI - Finlandia 251
RU - Federazione Russa 203
CZ - Repubblica Ceca 27
VN - Vietnam 23
IR - Iran 21
EU - Europa 20
JP - Giappone 20
BE - Belgio 17
CA - Canada 14
NL - Olanda 14
AT - Austria 12
CH - Svizzera 11
PL - Polonia 8
ES - Italia 7
MX - Messico 7
RO - Romania 7
CL - Cile 6
GR - Grecia 6
NZ - Nuova Zelanda 6
BR - Brasile 5
DK - Danimarca 5
AU - Australia 4
IL - Israele 4
CO - Colombia 3
HK - Hong Kong 3
MY - Malesia 3
PT - Portogallo 3
SM - San Marino 3
BD - Bangladesh 2
BO - Bolivia 2
KR - Corea 2
MA - Marocco 2
NO - Norvegia 2
PK - Pakistan 2
SI - Slovenia 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BG - Bulgaria 1
GH - Ghana 1
HU - Ungheria 1
KZ - Kazakistan 1
LU - Lussemburgo 1
ME - Montenegro 1
MO - Macao, regione amministrativa speciale della Cina 1
PA - Panama 1
PE - Perù 1
SC - Seychelles 1
TN - Tunisia 1
VE - Venezuela 1
Totale 17.085
Città #
Jacksonville 1.501
Chandler 1.351
Dublin 1.122
Southend 694
Princeton 571
Singapore 468
Izmir 454
Nanjing 442
Wilmington 298
Dearborn 260
Cambridge 242
Ashburn 216
Beijing 195
Altamura 164
Nanchang 149
Chieti 122
Ann Arbor 114
Woodbridge 108
Santa Clara 94
Boardman 91
Shenyang 84
Hebei 76
Tianjin 71
Jiaxing 62
Rome 62
Grevenbroich 53
Los Angeles 53
New York 52
Kunming 49
Houston 46
Milan 42
Washington 42
Norwalk 41
Hangzhou 37
Changsha 36
Jinan 34
Pescara 32
Lanzhou 28
Florence 22
Dong Ket 21
Orange 20
Taizhou 20
Augusta 19
Changchun 19
Ardabil 18
Falls Church 18
Ningbo 18
Hefei 17
Brno 16
Helsinki 15
Naples 13
Toronto 13
Zhengzhou 13
Brussels 12
Leawood 12
Ufa 12
Cepagatti 11
Guangzhou 10
London 10
Shanghai 10
San Mateo 9
Auburn Hills 8
Catania 8
Cedar Knolls 8
Hanover 8
Montesilvano 8
Mountain View 8
Napoli 8
Seattle 8
Teramo 8
Genova 7
Moscow 7
Olomouc 7
Paris 7
Torino 7
Verona 7
Campobasso 6
L'aquila 6
Lanciano 6
Mantova 6
Monmouth Junction 6
Palermo 6
Perugia 6
Bangalore 5
Cagliari 5
Casaleone 5
Caserta 5
Chicago 5
Fairfield 5
Kraków 5
Mexico City 5
Munich 5
Redwood City 5
Simi Valley 5
Tower Hamlets 5
Amsterdam 4
Andover 4
Capurso 4
Chiasso 4
Edinburgh 4
Totale 10.140
Nome #
Emergenza neurologica - tempesta distonica: diagnosi e terapia 333
EDONISMO OMEOSTATICO, COMPLICAZIONE RARA DELLA MALATTIA DI PARKINSON: 10 ANNI DI FOLLOW-UP. 271
La Mattis Dementia Rating Scale e la NPI messi al confronto nella valutazione della malattia di Alzheimer, demenza a corpi di Lewy diffusa e la malattia di Parkinson con Demenza, in una popolazione del centro Italia. 218
"Delirium Day": A nationwide point prevalence study of delirium in older hospitalized patients using an easy standardized diagnostic tool 150
Pre-trattamento antiematico per Test/terapia all'apomorfina 150
NUOVI MARKER DIAGNOSTICI NELLA DEMENZA A CORPI DI LEWY. 131
Le anomalie EEG precoci predicono la comparsa di fluttuazionicognitive nella con demenza. 121
Dropped head syndrome with necrotizing myopathy: A drug class effect confirmed by 3 repeated exposures to non ergolinic dopamine agonists, due to L-Dopa phobia 121
Specializzazione funzionale della corteccia visiva nell'uomo. Studio con risonanza magnetica funzionale e potenziali evocati visivi 113
TREMORE PSEUDO - ORTOSTATICO RESPONSIVO ALLA LEVO - DOPA IN PARKINSONISMO. 113
Quantitative electroencephalogram utility in predicting conversion of mild cognitive impairment to dementia with Lewy bodies 109
Updates on Somatoform Disorders (SFMD) in Parkinson's Disease and Dementia with Lewy Bodies and discussion of phenomenology. 106
The Characterization of Regulatory T-Cell Profiles in Alzheimer’s Disease and Multiple Sclerosis 105
Progetto atrofia multisistemica: risultati preliminari. 98
Fisiopatologia dei ritardi di conduzione nella sclerosi multipla 94
Thalamic Involvement in Fluctuating Cognition in Dementia with Lewy Bodies: Magnetic Resonance Evidences. 91
COMBINED REHABILITATION PROGRAM FOR POSTURAL INSTABILITY IN PROGRESSIVE SUPRANUCLEAR PALSY 89
Ascertainment bias in dementias: a secondary to tertiary centre analysis in Central Italy and conceptual review 89
Cortical Activation During Levitation and Tentacular Movements of Corticobasal Syndrome 88
Olanzapina: il nuovo trattamento della Sindrome di Gilles de La Tourette 87
Brainstem Midline Assessed by Transcranial Sonography in Parkinson's Disease: Further Evidence of a Different Etiopathogenesis of Alexithymia and Depression 87
Amyloid-specific T-cells differentiate Alzheimer's disease from Lewy body dementia 86
L’EEG nel Mild Cognitive Impairment (MCI): valore predittivo per lo sviluppo di demenza a corpi di Lewy. 86
Amygdala-vmPFC dysfunction as a marker of dementia in parkinsonism 86
Manifestazioni ossessivo-compulsive nella Malattia di Parkinson. 85
TRATTAMENTO CON TOSSINA BOTULINICA DELLA DISTONIA ASSIALE LATERALE NEL PARKINSONISMO. 85
Amygdala-vmPFC dysfunction as a marker of dementia in parkinsonism. 85
Akinetic crisis in Dementia with Lewy Bodies 85
Tolcapone vs entacapone: efficacia ed effetti collaterali nel trattamento della sindrome di Parkinson 84
Cohort study on Somatoform Disorders in Parkinson’s Disease and Dementia with Lewy Bodies 83
Eyelid retraction in dementia with Lewy Bodies and Parkinson’s Disease 83
Camptocormia nella Malattia di Parkinson e nella demenza a corpi di Lewy 83
Bipallidal lesions induce delayed and progressive parkinsonism 83
Persistent genital arousal disorder associated with functional hyperconnectivity of an epileptic focus. 82
Structural alteration of the dorsal visual network in DLB patients with visual hallucinations: a cortical thickness MRI study 82
Long half-life and prolonged-release receptor agonists:a review of ropinirole prolonged- release studies. 82
Visual Hallucinations in PD and Lewy body dementias: Old and new hypotheses 81
Mutation in the SYNJ1 gene associated with autosomal recessive, early-onset parkinsonism 81
Paradoxical kinesia in parkinsonian patients surviving earthquake. 81
Diagnosi differenziale tra malattia da prioni e possibile variante di demenza fronto-temporale: un caso clinico 80
P3 topography in brain lesions 79
Attention network in AD and DLB patients: a resting fMRI study. 79
Heat shock protein 70: implication for Alzheimer's disease 78
Autoscopic phenomena: case report and review of literature. 78
EEG comparison in early AD, LBD, PDD patients with a 2 years follow-up. 78
Morphological and metabolic changes in the nigro-striatal pathway of synthetic proteasome inhibitor (PSI)-treated rats: a MRI and MRS study 78
Structural connectivity is differently altered in dementia with Lewy body and Alzheimer’s disease 78
Are P300 asymmetries in focal brain lesions reference dependent? 77
3D localization of interictal epileptic activity by neuromagnetic method 77
Morphological and Metabolic Changes in the Nigro-Striatal Pathway of Synthetic Proteasome Inhibitor (PSI)-Treated Rats: A MRI and MRS Study. 77
Default mode network links to visual hallucinations: A comparison between Parkinson's disease and multiple system atrophy 77
Hand dystonia due to cervical lesions 77
Neurite ottica: relazione tra perimetria, PEV e RMN 76
Unsuccessful switch over from clozapine to olanzapine after clozapine-induced granulocytopenia in three psychotic Parkinson's disease patients 76
Pathological Gambling in PD is reduced by Amantadine 76
Improving diagnostic accuracy of DLB: An MRI study 76
Extra-hippocampal alteration of grey matter in dementia with Lewy bodies and Alzheimer’s disease 76
Valutazione dei potenziali evocativi visivi durante terapia con farmaci antipsicotici atipici in pazienti con schizofrenia 75
Polymorphisms of chemokine receptor genes in Alzheimer's and Parkinson's Patients 75
Registrazioni dei potenziali evocati visivi ed evento_correlati in un paziente affetto da sindrome di Balint 74
Amantadine for dyskinesia in patients affected by severe Parkinson's disease. 74
Two novel POLG1 mutations in a patient with progressive external ophthalmoplegia, levodopa-responsive pseudo-orthostatic tremor and parkinsonism. 74
Uso della amantadina nel trattamento delle discinesie e fluttuazioni motorie in pazienti affetti da Morbo di Parkinson 74
Are VEP abnormalities in optic neuritis (ON) dependent on plaque size? A reappraisal of the physiopathology of ON based on improved MRI and multiple-lead recordings. 73
Somatoform disorders in Parkinson’s Disease and Dementia with Lewy Bodies evidence underlying psychotic traits. 73
Effects of dexpramipexole on brain mitochondrial conductances and cellular bioenergetic efficiency 73
Valutazione dei potenziali evocati visivi durante terapia con farmaci antipsicotici atipici in pazienti con schizofrenia 73
Atrophy of hippocampal subfields and adjacent extrahippocampal structures in dementia with Lewy bodies and Alzheimer's disease 73
Mitochondrial Involvement in Neurodegenerative Dementia 73
Non dominant frontal-polar activity during high level chess problem solving 72
Functional specialization in human visual cortex: Evaluation by visual evoked potentials and fMRI 72
Acute akinesia or akinetic crisis in Parkinson's disease. 72
Delayed blink reflex in dementia with Lewy bodies is sensitive to cholinergic modulation. 72
Cohort study on tremor in DLB: prevalence and features 72
Camptocormia in Lewy Body disease (LBD) in comparison with Parkinson’s Disease (PD) 72
Atrofia Multisistemica: approccio diagnostico multidisciplinare 72
Post traumatic stress disorder heralding the onset of semantic frontotemporal dementia 72
Echo long time STIR sequence magnetic resonance imaging of optic nerves in optic neuritis 71
Donepezil vs vitamina E nella malattia di Alzheimer (AD): confronto tra P300 Event Related Potential e Test Neuropsicologici. 71
Leucopenia induced by low dose clozapine in Parkinson's disease recedes shortly after drug withdrawal. Clinical case descriptions with commentary on switch-over to olanzapine. 71
Altitudinal visual stimuli and the cruciform model of evoked potentials. 71
Mixed resting and postural tremor with overflow in orthostatism is observed in PDD/DLB patients 71
Cortical rhythms in ad, LBD and normal subjects: A quantitative meg study 71
EEG comparisons in early Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease with dementia patients with a 2-year follow-up 71
Amantadine and antiglutamatergic drugs in the management of Parkinson’s disease 71
Attivazione dell'emisfero non-dominante in giocatori di scacchi durante la soluzione di complessi problemi strategici 70
Emergencies in parkinsonism: akinetic crisis, life-threatening dyskinesias, and polyneuropathy during L-Dopa gel treatment. 70
Amyloid B-1-42 stimulated T cells express protein kinase C-delta and/or protein kinase C-Z in Alzheimer disease. 70
Prevalenza dei disturbi motori e non motori nella popolazione di pazienti con demenza a corpi di Lewy afferente al nostro centro per i disordini del movimento e le demenze. 70
Immunological involvement in the pathogenesis of Parkinson's disease 69
End-of-dose deterioration in non ergolinic dopamine agonist monotherapy of Parkinson's disease. 69
L’ecografia transcranica nello studio del parenchima cerebrale: la nostra casistica 69
Donepezil versus vitamin E in Alzheimer's Disease part 2: Mild versus moderate-severe Alzheimer's Disease 69
Severe worsening of parkinsonism in Lewy body dementia due to donepezil 69
New approaches to understanding hallucinations in Parkinson’s Disease: phenomenology and possible origins. 68
STUDIO DELLE COMPONENTI DI MEMBRANA DI UN PUTATIVO CANALE MITOCONDRIALE LEGATO ALLA MORTE CELLULARE IN UN MODELLO ANIMALE DI MALATTIA DI PARKINSON. 68
PSI proteasome inhibitor induced rat model of Parkinson’s Disease. 68
The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design 68
Newborns with hyperbilirubinemia: usefulness of brain stem auditory response evaluation. 67
An expert opinion on safinamide in Parkinson's disease 67
Totale 8.719
Categoria #
all - tutte 61.271
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.271


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.250 0 238 19 132 216 228 368 341 109 235 336 28
2020/20211.690 278 19 288 30 143 357 42 35 77 221 111 89
2021/20221.095 27 25 27 130 61 31 26 96 71 46 176 379
2022/20233.759 305 436 247 393 374 765 242 249 497 55 93 103
2023/20241.730 133 75 128 87 93 436 431 52 37 63 31 164
2024/2025997 268 729 0 0 0 0 0 0 0 0 0 0
Totale 17.732